tirzepatide and menopause Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 Tirzepatide with hormone therapy boosts

Risks and Benefits of LongTerm GLP1 Use Benefits Sustained appetite control Improved blood sugar regulation Lower shortterm risk of weight regain Support while new lifestyle habits solidify Risks Prolonged exposure to mild side effects (e.g., nausea, constipation) Rare complications (e.g., pancreatitis, gallbladder issues) Higher cumulative cost over time Key point: Longterm therapy can be safe with medical monitoring, but periodic reevaluation ensures continued necessity

Mojsov has a degree in physical chemistry from the University of Belgrade, Serbia and obtained a PhD from Rockefeller University, US

These hormones play crucial roles in regulating blood sugar and influencing appetite

Most patients experience peak constipation during the first 24 weeks, with significant improvement by week 68 as your gut microbiome adapts

These symptoms may be a sign that your body needs time to adapt to the medication, or it could indicate a need to adjust your dosage

This simplicity is one of the advantages of brand-name pens